Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements
Press Releases
January 24, 2025

Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements

NEW YORK, Jan. 24, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the "Company" or "Hoth Therapeutics"), a biopharmaceutical company, today announced that it has received notification from the Listing

bradford

The Bradford Era

Local & Social